R. Strang

发表

Molecular hybridization yields triazole bronchodilators for the treatment of COPD.

M. Trevethick, E. Stuart, P. Glossop, 2015, Bioorganic & medicinal chemistry letters.

Biologically Active Recombinant Human Progastrin6–80Contains a Tightly Bound Calcium Ion*

A. Paterson, G. Baldwin, A. Shulkes, 2001, The Journal of Biological Chemistry.

Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.

M. Bunnage, David A. Price, A. Wood, 2011, Journal of medicinal chemistry.

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.

G. Rummel, R. Wolf, F. Zécri, 2017, ACS medicinal chemistry letters.

Development of a Scaleable Synthesis of a Geminal Dimethyl Tertiary Amine as an Inhaled Muscarinic Antagonist for the Treatment of COPD

D. Entwistle, P. Glossop, Barry. R. Dillon, 2012 .

Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors.

D. Owen, R. Bazin, K. Dack, 2011, Bioorganic & medicinal chemistry letters.

Structure-based and property-driven optimization of N-aryl imidazoles towards potent and selective oral RORγt inhibitors.

S. Hintermann, P. Ertl, M. Streiff, 2019, Journal of medicinal chemistry.

Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor.

D. J. Bull, M. Bunnage, D. Owen, 2010, Bioorganic & medicinal chemistry letters.

Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.

E. Vangrevelinghe, Christian C. Lee, G. Thoma, 2015, Bioorganic & medicinal chemistry letters.